Clinical Trial Update: A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD [Phase 2]

View source ↗

Summary

Phase 2 pilot study evaluating everolimus on brain mTOR activity and cortical hyperexcitability in epilepsy related to tuberous sclerosis complex and focal cort…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Focal Cortical Dysplasia
• Tuberous Sclerosis Complex

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: NYU Langone Health | Conditions: Epilepsy, Tuberous Sclerosis Complex | Phase 2 | Status: COMPLETED | Results posted: 2021-09-01